The Vallejo Day Treatment Program has its primary purpose to provide medically supervised out-patient detoxification and intensive treatment for chemically dependent patients. We believe that chemical dependency is a primary, progressive disease that may be fatal if left untreated. Recovery from alcohol/drug addiction happens in phases. Our program assists patients to successfully complete their first phase of recovery by providing a minimum of 14 consecutive days of education, professional counseling and support in a safe and caring environment. We are committed to the long-term recovery of our patients. In our view, optimal recovery results from a combination of factors: the individual’s commitment and effort along with ongoing professional help, support from family and friends, and, participation in self-help groups. We therefore encourage our patients to transition into our Intensive Recovery Program (IRP), to actively participate in 12-Step or other community based support groups and to invite their spouses, parents, or adult children to enroll in our program for family members.
The next step in building your foundation is the challenge of moving from Day Treatment into a Follow-Up Program. When you transition from Day Treatment you and your counselor develop a Discharge or Follow-Up program. If you stay here in Vallejo, your next step will probably be the Intensive Recovery Program (IRP). Daily Phase 1 attendance is to help you transition into a less structured program. There are many variable IRP schedules. You are also responsible for keeping a “Tick Sheet” which you use to track your progress through Phases 1 and 2. Tick Sheets are in the publication racks in the lobby and Room A.
This program is composed of an eight-week ongoing educational series (which includes the above four-part series) and a support group for the Kaiser member who wonders if, or has been told by others, that he or she might have a substance use problem.
Call (707) 651-1050 for information about the timing of these groups.
Studies have shown that, in addition to psychological treatment and therapy, some addictions are best treated with medications which help people feel normal and reduce the risks of overdose or death.
There are currently two agonist maintenance medications approved by the FDA to treat opioid addiction: methadone and buprenorphine, both of which are opiates.
Methadone is restricted to specially licensed clinics called Opioid Treatment Programs, and its use is carefully regulated by federal and state agencies.
Buprenorphine can be prescribed in an office or chemical dependency treatment setting by specially licensed physicians and is also bound by some regulations. At Kaiser Permanente Addiction Medicine Recovery Services, patients on buprenorphine will be asked to participate in an individualized treatment program at AMRS.
Further information about either medication can be discussed with your therapist or provider during your visit.